EULAR responses of patients with psoriatic arthritis at Months 3 and 6. Patients are classified by low-affinity and high-affinity FCGR2A and FCGR3A genotypes.
| FCGR2A, n (%) | FCGR3A, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| EULAR Response | HH + HR (High affinity) | RR (Low affinity) | Total | p* | VV + VF (High affinity) | FF (Low affinity) | Total | p* |
| 3 months, n = 103 | ||||||||
| None | 10 (12) | 5 (23) | 15 (15) | 0.304 | 11 (14) | 4 (15) | 15 (15) | 1.000 |
| Moderate + Good | 71 (88) | 17 (77) | 88 (85) | 66 (86) | 22 (85) | 88 (85) | ||
| 6 months, n = 103 | ||||||||
| None | 7 (9) | 6 (27) | 13 (13) | 0.030 | 10 (13) | 3 (12) | 13 (13) | 1.000 |
| Moderate + Good | 74 (91) | 16 (73) | 90 (87) | 67 (87) | 23 (88) | 90 (87) | ||
↵* Fisher’s exact test. EULAR: European League Against Rheumatism.